An Assessment of Serum Selenium Concentration in Women with Ovarian Cancer.

Marek Kluza Sylwia PaszekKatarzyna KluzaSlawomir M Januszek Natalia PotockaMarzena SkrzypaAlina ZuchowskaAndrzej WrobelPiotr BaszukWojciech Marciniak Marcin Misiek Jan A Lubiński Jacek GronwaldIzabela ZawlikTomasz Kluz

Published in: Nutrients (2023)

The studied patients with ovarian cancer are characterized by statistically significant lower serum selenium levels than patients from the control group. Among the study group, a decrease in selenium concentration was observed with an increase in the FIGO stage. The determination of the role of selenium as a prophylactic factor in ovarian cancer requires further prospective studies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
mass spectrometry